Lamont D D, Passi R B
Department of Surgery, University Hospital, University of Western Ontario, London.
Can J Surg. 1989 Jan;32(1):15-8.
Endoscopic sphincterotomy is the treatment of choice for choledocholithiasis after cholecystectomy. Its role has been expanded to treat choledocholithiasis in patients with gallbladders still in place. The authors report their experience with endoscopic sphincterotomy, with emphasis on the safety of the procedure, in high-operative-risk patients with choledocholithiasis and gallbladder in situ. Stones were successfully removed in 72 of 75 patients (96%); 1 required an emergency operation and 2 an elective one. Complications included bleeding, pancreatitis and cholangitis; there were no associated deaths. Follow-up of 54 of the patients, who had associated cholelithiasis at the time of endoscopic sphincterotomy, showed that 14 died of causes unrelated to the biliary tract. Of the others, 14 underwent cholecystectomy for failure of endoscopic sphincterotomy (2), acute cholecystitis (4) or persistent biliary tract symptoms (8). The other 26 patients were well after a mean follow-up of 30.4 months; 1 had mild biliary tract symptoms. Ultrasonography in 16 of the 26 patients showed persistent cholelithiasis in 12. Life-table analysis revealed a 15% probability of acute cholecystitis within 5 years of endoscopic sphincterotomy.
内镜括约肌切开术是胆囊切除术后胆总管结石的首选治疗方法。其作用已扩展至治疗胆囊仍在位患者的胆总管结石。作者报告了他们在内镜括约肌切开术方面的经验,重点关注该手术在有胆总管结石且胆囊在位的高手术风险患者中的安全性。75例患者中有72例(96%)结石成功取出;1例需要急诊手术,2例需要择期手术。并发症包括出血、胰腺炎和胆管炎;无相关死亡病例。对在内镜括约肌切开术时伴有胆结石的54例患者进行随访,结果显示14例死于与胆道无关的原因。其余患者中,14例因内镜括约肌切开术失败(2例)、急性胆囊炎(4例)或持续性胆道症状(8例)而接受了胆囊切除术。另外26例患者在平均随访30.4个月后情况良好;1例有轻度胆道症状。26例患者中的16例接受超声检查,其中12例显示有持续性胆结石。生命表分析显示,内镜括约肌切开术后5年内发生急性胆囊炎的概率为15%。